Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,991 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A phase I, double blind, randomized, placebo-controlled, study of two dosages.
Tambyah PA, Oon J, Asli R, Kristanto W, Hwa SH, Vang F, Karwal L, Fuchs J, Santangelo JD, Gordon GS, Thomson C, Rao R, Dean H, Das SC, Stinchcomb DT. Tambyah PA, et al. Among authors: rao r. Vaccine. 2019 Jul 18;37(31):4344-4353. doi: 10.1016/j.vaccine.2019.06.023. Epub 2019 Jun 20. Vaccine. 2019. PMID: 31230881 Free article. Clinical Trial.
Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
Kanungo S, Paisley A, Lopez AL, Bhattacharya M, Manna B, Kim DR, Han SH, Attridge S, Carbis R, Rao R, Holmgren J, Clemens JD, Sur D. Kanungo S, et al. Among authors: rao r. Vaccine. 2009 Nov 16;27(49):6887-93. doi: 10.1016/j.vaccine.2009.09.008. Epub 2009 Sep 15. Vaccine. 2009. PMID: 19761838 Clinical Trial.
A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India.
Mahalanabis D, Lopez AL, Sur D, Deen J, Manna B, Kanungo S, von Seidlein L, Carbis R, Han SH, Shin SH, Attridge S, Rao R, Holmgren J, Clemens J, Bhattacharya SK. Mahalanabis D, et al. Among authors: rao r. PLoS One. 2008 Jun 4;3(6):e2323. doi: 10.1371/journal.pone.0002323. PLoS One. 2008. PMID: 18523643 Free PMC article. Clinical Trial.
Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3 years of follow-up of a randomized, controlled trial.
Sur D, Kanungo S, Sah B, Manna B, Ali M, Paisley AM, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Han SH, Attridge S, Donner A, Ganguly NK, Bhattacharya SK, Nair GB, Clemens JD, Lopez AL. Sur D, et al. Among authors: rao r. PLoS Negl Trop Dis. 2011 Oct;5(10):e1289. doi: 10.1371/journal.pntd.0001289. Epub 2011 Oct 18. PLoS Negl Trop Dis. 2011. PMID: 22028938 Free PMC article. Clinical Trial.
Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial.
Sur D, Lopez AL, Kanungo S, Paisley A, Manna B, Ali M, Niyogi SK, Park JK, Sarkar B, Puri MK, Kim DR, Deen JL, Holmgren J, Carbis R, Rao R, Nguyen TV, Donner A, Ganguly NK, Nair GB, Bhattacharya SK, Clemens JD. Sur D, et al. Among authors: rao r. Lancet. 2009 Nov 14;374(9702):1694-702. doi: 10.1016/S0140-6736(09)61297-6. Epub 2009 Oct 8. Lancet. 2009. PMID: 19819004 Clinical Trial.
Evaluation of the immunogenicity and safety of an indigenously developed DTwP-Hib tetravalent combination vaccine (Shan 4) with EasyFourTM in Indian infants administered per EPI schedule: a phase III trial.
Dhingra MS, Rao R, Bhat S, Joshi R, Kalra V, Parikh HR, Rao SN, Sethi GR, Shah N, Muzaffaruddin M. Dhingra MS, et al. Among authors: rao r, rao sn. Hum Vaccin. 2010 Jul;6(7):572-7. doi: 10.4161/hv.6.7.11817. Hum Vaccin. 2010. PMID: 20421723 Free PMC article. Clinical Trial.
A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (liq) and TritanrixHB + Hiberix (lyo) in Indian infants administered according to the EPI schedule.
Rao R, Dhingra MS, Bavdekar S, Behera N, Daga SR, Dutta AK, Kundu R, Maiya P, Mishra P, Shah R, Shuba S, Tibrewala V, Pandhi S, Rajamani AM. Rao R, et al. Hum Vaccin. 2009 Jun;5(6):425-9. doi: 10.4161/hv.5.6.7816. Epub 2009 Jun 12. Hum Vaccin. 2009. PMID: 19333002 Clinical Trial.
Attitudes to long-term care in India: A secondary, mixed methods analysis.
Alberts S, Nadarajah A, Cooper C, Brijnath B, Loganathan S, Varghese M, Antoniades J, Baruah U, Dow B, Kent M, Rao R, Budgett J, Ahmed A. Alberts S, et al. Among authors: rao r. Int J Geriatr Psychiatry. 2024 Jun;39(6):e6107. doi: 10.1002/gps.6107. Int J Geriatr Psychiatry. 2024. PMID: 38822577
3,991 results